Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR0410 for postoperative analgesia after laparoscopic surgery
ChiCTR2200062370Phase 3Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of SHR0410 in postoperative pain (3 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: NRS pain intensity score, Pain relief score and 5 more. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
SHR0410
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2200062370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062370.